Pathophysiological mechanisms and biomarkers of alopecia areata

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032875

Enrollment

Registered

2023-10-19

Start date

2023-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L63.9

Interventions

Group 1: Adult patients with physician diagnosed alopecia areata - Questionnaires / Scores: AA Quality of Life Index (AA-LQI), Dermatology Life Quality Index (DLQI), Center for Epidemiologic Studies

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Physician diagnosed alopecia areata Consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding patients Lack of understanding of the study protocol / language barrier Causes other than alopecia areata for hair loss Lack of willingness to actively participate in the study

Design outcomes

Primary

Measure	Time frame
Identification of biomarkers for the prediction of disease progression	—

Secondary

Measure	Time frame
Differences in the molecular signature in different disease manifestations	—

Countries

Germany

Contacts

Public ContactThomas Werfel

Klinik für Dermatologie, Allergologie und Venerologie

werfel.thomas@mh-hannover.de0511-532-7654

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026